Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLN.L Share News (SLN)

  • There is currently no data for SLN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK DIRECTOR DEALINGS SUMMARY: Tesco's Simon Patterson Buys Shares

Mon, 12th Oct 2020 22:10

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Monday and not separately reported by Alliance News:

----------

Tesco PLC - supermarket chain headquartered in Welwyn Garden City - Director Simon Patterson buys 70,423 shares for GBP2.1118 each, worth GBP148,719 on Thursday.

----------

Silence Therapeutics PLC - novel RNA therapeutics developer - Chair Iain Ross buys 9,750 shares for GBP4.10 each, worth GBP39,976, on Thursday. Now interested in 54,443 ordinary shares. Non-Executive Director James Ede-Golightly buys 3,000 shares, also on Thursday, at GBP4.0875 each for GBP12,263, his entire holding. Executive Director Giles Campion buys 4,945 shares at GBP4.04 each for GBP19,978 on Friday and is now interested in 14,945 shares.

----------

Harworth Group PLC - Rotherham-based property developer - Chief Executive Officer-elect Lynda Shillaw buys 52,545 shares for GBP0.947 each, worth GBP49,760 on Monday.

----------

Photo-Me International PLC - Epsom, Surrey-based operator of instant-service equipment, such as photobooths and self-service laundry - Tibergest PTE Ltd, closely associated with Chief Executive & Deputy Chair Serge Crasnianski, buys 2.5 million shares at 53 pence each on Friday, worth GBP1.3 million. Crasnianski is ultimate beneficial owner of Tibergest and he and his associates hold 100.1 million shares in Photo-Me, representing a 26% stake. Chief Financial Officer Stephane Gibon buys 40,000 shares at 50 pence each on Friday worth GBP20,000, now interested in 140,000 shares.

----------

TP ICAP PLC - FTSE 250 interdealer broker based in London - Chief Executive Officer Nicolas Breteau buys 10,000 shares at GBP2.30 each on Friday, worth GBP23,000.

----------

ICG-Longbow Senior Secured UK Property Debt Investments Ltd - UK real estate debt-related investment - close associate of Non Executive Director Paul Meader, Paul Meader Retirement Annuity Trust Scheme, buys 50,000 shares at 74.2333 pence each on Friday, worth GBP37,117.

----------

By Anna Farley; annafarley@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
26 Nov 2021 12:59

IN BRIEF: Silence Therapeutics to delist from AIM next week

IN BRIEF: Silence Therapeutics to delist from AIM next week

Read more
26 Nov 2021 09:53

Silence Therapeutics to proceed with AIM delisting next week

(Sharecast News) - Silence Therapeutics updated the market on the planned cancellation of its shares on AIM on Friday, which it originally announced on 15 October.

Read more
16 Nov 2021 12:23

TRADING UPDATES: Focusrite profit jumps; Gear4Music strikes bum note

TRADING UPDATES: Focusrite profit jumps; Gear4Music strikes bum note

Read more
16 Nov 2021 11:39

Revenue, expenses rise in third quarter for Silence Therapeutics

(Sharecast News) - Silence Therapeutics said on Tuesday that its revenue increased by £1.2m year-on-year in its third quarter, as a result of the further advancement of its partner programmes, as well as the introduction of additional programmes with its partners.

Read more
5 Nov 2021 18:40

IN BRIEF: Frazier Life picks up 3% interest in Silence Therapeutics

IN BRIEF: Frazier Life picks up 3% interest in Silence Therapeutics

Read more
5 Nov 2021 11:39

Frazier Life Sciences becomes 'important' new Silence Therapeutics shareholder

(Sharecast News) - Novel short interfering ribonucleic acid (siRNA) therapy developer Silence Therapeutics announced on Friday that healthcare-focussed investor Frazier Life Sciences Public Fund had purchased about $20m of its existing shares.

Read more
25 Oct 2021 16:03

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
22 Oct 2021 20:26

IN BRIEF: Silence Therapeutics reports solid progress across pipelines

IN BRIEF: Silence Therapeutics reports solid progress across pipelines

Read more
15 Oct 2021 15:40

CORRECT: Silence Therapeutics to delist from AIM; teams with Hansoh

CORRECT: Silence Therapeutics to delist from AIM; teams with Hansoh

Read more
15 Oct 2021 14:15

IN BRIEF: Silence Therapeutics to delist from AIM; unites with Hansoh

IN BRIEF: Silence Therapeutics to delist from AIM; unites with Hansoh

Read more
15 Oct 2021 12:23

Silence Therapeutics inks collaboration deal with Hansoh Pharmaceutical

(Sharecast News) - Silence Therapeutics announced a collaboration with Hansoh Pharmaceutical Group on Friday, to develop short interfering ribonucleic acids (siRNAs) for three undisclosed targets, leveraging its proprietary 'mRNAi GOLD' platform.

Read more
1 Sep 2021 09:30

Silence promotes John Strafford to head new product development

(Sharecast News) - Silence Therapeutics announced the appointment of John Strafford to the newly-created role of senior vice-president of business development, alliance management and new product development on Wednesday, effective immediately.

Read more
12 Aug 2021 13:56

IN BRIEF: Silence Therapeutics revenue up, new targets with AstraZeneca

IN BRIEF: Silence Therapeutics revenue up, new targets with AstraZeneca

Read more
12 Aug 2021 09:37

Silence Therapeutics losses widen as it progresses programmes

(Sharecast News) - Silence Therapeutics reported revenues from collaborations of £5.8m in its first half on Thursday, up from £1.1m year-on-year, which it put down to its work with AstraZeneca and Mallinckrodt.

Read more
5 Aug 2021 16:18

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.